Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders

Markus Wolff Katrine M. Johannesen Ulrike B. S. Hedrich Silvia Masnada Guido Rubboli Elena Gardella Gaetan Lesca 1 Dorothée Ville 1 Mathieu Milh 2 Laurent Villard 1 Alexandra Afenjar 3 Sandra Bast Cyril Mignot 4 Caroline Lardennois Caroline Nava 5 Niklas Schwarz Marion Gérard 6 Laurence Perrin 7 Diane Doummar 8 Stéphane Auvin 9 Maria J. Miranda Maja Hempel 10 Eva Brilstra Nine Knoers 11 Nienke Verbeek Marjan Van Kempen Kees P. Braun Grazia Mancini Saskia Biskup 12 Konstanze Hörtnagel 12 Miriam Döcker Thomas Bast 13 Tobias Loddenkemper Lily Wong-Kisiel Friedrich M. Baumeister Walid Fazeli Pasquale Striano 14 Robertino Dilena Elena Fontana 15 Federico Zara 14 Gerhard Kurlemann Joerg Klepper Jess G. Thoene Daniel H. Arndt Nicola Deconinck Thomas Schmitt-Mechelke Oliver Maier Hiltrud Muhle Beverly Wical Claudio Finetti Reinhard Brückner Joachim Pietz Günther Golla Dinesh Jillella Karen M. Linnet 16 Perrine Charles Ute Moog 17 Eve Õiglane-Shlik John F. Mantovani Kristen Park Marie Deprez Damien Lederer 18 Sandrine Mary Emmanuel Scalais Laila Selim Rudy Van Coster 19 Lieven Lagae 20 Marina Nikanorova Helle Hjalgrim 21 G. Christoph Korenke Marina Trivisano Nicola Specchio Berten Ceulemans Thomas Dorn Katherine L. Helbig 22 Katia Hardies 23 Hannah Stamberger Peter De Jonghe 24 Sarah Weckhuysen 25 Johannes R. Lemke Ingeborg Krägeloh-Mann 26 Ingo Helbig 27 Gerhard Kluger 28 Holger Lerche Rikke S Møller
Abstract : Mutations in SCN2A, a gene encoding the voltage-gated sodium channel Nav1.2, have been associated with a spectrum of epilepsies and neurodevelopmental disorders. Here, we report the phenotypes of 71 patients and review 130 previously reported patients. We found that (i) encephalopathies with infantile/childhood onset epilepsies (≥3 months of age) occur almost as often as those with an early infantile onset (<3 months), and are thus more frequent than previously reported; (ii) distinct phenotypes can be seen within the late onset group, including myoclonic-atonic epilepsy (two patients), Lennox-Gastaut not emerging from West syndrome (two patients), and focal epilepsies with an electrical status epilepticus during slow sleep-like EEG pattern (six patients); and (iii) West syndrome constitutes a common phenotype with a major recurring mutation (p.Arg853Gln: two new and four previously reported children). Other known phenotypes include Ohtahara syndrome, epilepsy of infancy with migrating focal seizures, and intellectual disability or autism without epilepsy. To assess the response to antiepileptic therapy, we retrospectively reviewed the treatment regimen and the course of the epilepsy in 66 patients for which well-documented medical information was available. We find that the use of sodium channel blockers was often associated with clinically relevant seizure reduction or seizure freedom in children with early infantile epilepsies (<3 months), whereas other antiepileptic drugs were less effective. In contrast, sodium channel blockers were rarely effective in epilepsies with later onset (≥3 months) and sometimes induced seizure worsening. Regarding the genetic findings, truncating mutations were exclusively seen in patients with late onset epilepsies and lack of response to sodium channel blockers. Functional characterization of four selected missense mutations using whole cell patch-clamping in tsA201 cells—together with data from the literature—suggest that mutations associated with early infantile epilepsy result in increased sodium channel activity with gain-of-function, characterized by slowing of fast inactivation, acceleration of its recovery or increased persistent sodium current. Further, a good response to sodium channel blockers clinically was found to be associated with a relatively small gain-of-function. In contrast, mutations in patients with late-onset forms and an insufficient response to sodium channel blockers were associated with loss-of-function effects, including a depolarizing shift of voltage-dependent activation or a hyperpolarizing shift of channel availability (steady-state inactivation). Our clinical and experimental data suggest a correlation between age at disease onset, response to sodium channel blockers and the functional properties of mutations in children with SCN2A-related epilepsy.
Type de document :
Article dans une revue
Brain - A Journal of Neurology , Oxford University Press (OUP), 2017, 140 (5), pp.1316-1336. 〈10.1093/brain/awx054〉
Liste complète des métadonnées

Littérature citée [71 références]  Voir  Masquer  Télécharger

https://hal-amu.archives-ouvertes.fr/hal-01668653
Contributeur : Laurent Villard <>
Soumis le : vendredi 23 mars 2018 - 16:57:43
Dernière modification le : vendredi 16 novembre 2018 - 02:11:35
Document(s) archivé(s) le : mardi 11 septembre 2018 - 17:57:34

Fichier

awx054_biffé.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Markus Wolff, Katrine M. Johannesen, Ulrike B. S. Hedrich, Silvia Masnada, Guido Rubboli, et al.. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders. Brain - A Journal of Neurology , Oxford University Press (OUP), 2017, 140 (5), pp.1316-1336. 〈10.1093/brain/awx054〉. 〈hal-01668653〉

Partager

Métriques

Consultations de la notice

354

Téléchargements de fichiers

36